Takeda grants 45,140 RSUs to transformation chief

Duprey Lauren Rusckowski reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Duprey Lauren Rusckowski reported acquisition or exercise transactions in this Form 4 filing.

Takeda Pharmaceutical granted Chief Transformation Officer Lauren Rusckowski Duprey an award of 45,140 restricted stock units, each representing one American Depositary Share, at no cash price. The RSUs vest in three equal annual installments beginning on July 1, 2027. Following this equity award, she directly holds 273,643 American Depositary Shares.

Insider Trade Summary

Grant/Award: 45,140 shares

Grant/Award 1 txn

Insider Duprey Lauren Rusckowski

Role Chief Transformation Officer

Type	Security	Shares	Price	Value
Grant/Award	American Depositary Shares	45,140	$0.00	$0.00

Holdings After Transaction: American Depositary Shares — 273,643 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Key Figures

RSUs granted: 45,140 units Grant price: $0.00 per share Post-grant holdings: 273,643 ADS +1 more

4 metrics

RSUs granted 45,140 units Restricted stock units tied to American Depositary Shares

Grant price $0.00 per share Equity award, non-cash compensation

Post-grant holdings 273,643 ADS Shares directly held after the transaction

Vesting schedule 3 equal annual installments Beginning July 1, 2027 for RSU grant

Key Terms

restricted stock units (RSUs), American Depositary Shares, vest, Grant, award, or other acquisition

4 terms

restricted stock units (RSUs) financial

"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

American Depositary Shares financial

"Each RSU represents a contingent right to receive one American Depositary Share."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

vest financial

"The RSUs vest in three equal annual installments beginning on July 1, 2027."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Takeda (TAK) disclose in this Form 4 for Lauren Rusckowski Duprey?

Takeda reported that Chief Transformation Officer Lauren Rusckowski Duprey received a grant of 45,140 restricted stock units, each tied to one American Depositary Share, as equity compensation. This is a non-cash award reflecting part of her long-term incentive package.

How many Takeda (TAK) shares were granted to Lauren Rusckowski Duprey?

Lauren Rusckowski Duprey was granted 45,140 restricted stock units linked to Takeda American Depositary Shares. Each unit represents a right to receive one ADS, increasing her potential future ownership if vesting conditions are satisfied over time.

When do the newly granted Takeda (TAK) RSUs vest for Lauren Rusckowski Duprey?

The RSUs vest in three equal annual installments starting July 1, 2027. This means one-third of the 45,140 units will vest each year over three years, aligning her long-term incentives with Takeda’s future performance and retention goals.

Did Lauren Rusckowski Duprey buy Takeda (TAK) shares in the market?

No, the Form 4 shows a grant classified as an acquisition by award, not an open-market purchase. The 45,140 American Depositary Shares were awarded at a price of $0.00 per share as part of her compensation structure.

How many Takeda (TAK) American Depositary Shares does Lauren Rusckowski Duprey hold after this grant?

After the equity award, Lauren Rusckowski Duprey directly holds 273,643 American Depositary Shares. This reported figure reflects her post-transaction position and shows the scale of her direct ownership stake in Takeda.

What does transaction code "A" mean in Takeda (TAK) insider filings?

Transaction code “A” in this context indicates a grant, award, or other acquisition of securities. For Takeda, it means Lauren Rusckowski Duprey received 45,140 restricted stock units as compensation rather than buying shares in an open-market transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 06:03 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duprey Lauren Rusckowski

(Last) (First) (Middle)

45-55 HAYDEN AVE.

(Street)

LEXINGTON MASSACHUSETTS 02139

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Transformation Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
American Depositary Shares	07/01/2026		A		45,140(1)	A	$0	273,643	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Remarks:

	/s/ Kate Huleatt, by power of attorney, for Lauren R. Duprey	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)